• Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

D7G:GR

0.111 EUR 0.002 1.77%

As of 13:20:06 ET on 09/19/2014.

Snapshot for DiaGenic ASA (D7G)

Open: 0.114 Day's Range: 0.109 - 0.114 Volume: 0
Previous Close: 0.113 52wk Range: 0.056 - 0.300 1-Yr Rtn: +22.16%

Stock Chart for D7G

No chart data available.
  • D7G:GR 0.111
  • 1D
  • 1M
  • 1Y
0.113
Interactive D7G Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for D7G

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (NOK) (ttm) -
Est. EPS (NOK) (12/2014) -
Est. PEG Ratio -
Market Cap (M EUR) 12.01
Shares Outstanding (M) 108.16
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/06/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for D7G

  • Revenue
  • Net Income (M/NOK)
  • Profit Margin (%)

Company Profile & Key Executives for D7G

DiaGenic ASA is a biotechnology company. The Company has patents, pending and granted, for a method of preparing a standard diagnostic gene transcript pattern characteristic for a specific disease.

Ruben EkbratenInterim CEO/CFOMagnus SjogrenChief Medical Officer
Edith RianDir:OperationsMorten Sten JohansenDir:Intl Business
More Company Profile & Key Executives for D7G

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil